» Articles » PMID: 36854900

Gpr75-deficient Mice Are Protected from High-fat diet-induced Obesity

Abstract

Objective: G-protein coupled receptor 75 (GPR75) has been identified as the high-affinity receptor of 20-hydroxyeicosatetraenoic acid (20-HETE), a vasoactive and proinflammatory lipid, and mice overproducing 20-HETE have been shown to develop insulin resistance when fed a high-fat diet (HFD), which was prevented by a 20-HETE receptor blocker. Simultaneously, a large-scale exome sequencing of 640,000 subjects identified an association between loss-of-function GPR75 variants and protection against obesity.

Methods: Wild-type (WT) and Gpr75-deficient mice were placed on HFD for 14 weeks, and their obesity phenotype was examined.

Results: Male and female Gpr75 null (knockout [KO]) and heterozygous mice gained less weight than WT mice when placed on HFD. KO mice maintained the same level of energy expenditure during HFD feeding, whereas WT mice showed a significant reduction in energy expenditure. Diet-driven adiposity and adipocyte hypertrophy were greatly lessened in Gpr75-deficient mice. HFD-fed KO mice did not develop insulin resistance. Adipose tissue from Gpr75-deficient mice had increased expression of thermogenic genes and decreased levels of inflammatory markers. Moreover, insulin signaling, which was impaired in HFD-fed WT mice, was unchanged in KO mice.

Conclusions: These findings suggest that GPR75 is an important player in the control of metabolism and glucose homeostasis and a likely novel therapeutic target to combat obesity-driven metabolic disorders.

Citing Articles

Adopting GPR75 in treating obesity: unraveling the knowns and unknowns of this orphan GPCR.

Jiang Y, Zhang Z Trends Cell Biol. 2025; 35(2):102-104.

PMID: 39794254 PMC: 11805625. DOI: 10.1016/j.tcb.2024.12.006.


The expanding landscape of genetic causes of obesity.

Semenova E, Guo A, Liang H, Hernandez C, John E, Thaker V Pediatr Res. 2024; .

PMID: 39690244 DOI: 10.1038/s41390-024-03780-6.


Ciliary localization of GPR75 promotes fat accumulation in mice.

Chavez M, Asthana A, Jackson P J Clin Invest. 2024; 134(19).

PMID: 39352389 PMC: 11444157. DOI: 10.1172/JCI185059.


Effect and mechanism of GPR75 in metabolic dysfunction-related steatosis liver disease.

Wang S, Gao S, Wang F Int J Med Sci. 2024; 21(12):2343-2347.

PMID: 39310267 PMC: 11413904. DOI: 10.7150/ijms.101094.


Central regulation of feeding and body weight by ciliary GPR75.

Jiang Y, Xun Y, Zhang Z J Clin Invest. 2024; 134(19).

PMID: 39137039 PMC: 11444156. DOI: 10.1172/JCI182121.


References
1.
Akbari P, Gilani A, Sosina O, Kosmicki J, Khrimian L, Fang Y . Sequencing of 640,000 exomes identifies variants associated with protection from obesity. Science. 2021; 373(6550). PMC: 10275396. DOI: 10.1126/science.abf8683. View

2.
Levine J, Oleaga C, Eren M, Amaral A, Shang M, Lux E . Role of PAI-1 in hepatic steatosis and dyslipidemia. Sci Rep. 2021; 11(1):430. PMC: 7801442. DOI: 10.1038/s41598-020-79948-x. View

3.
Issan Y, Hochhauser E, Guo A, Gotlinger K, Kornowski R, Leshem-Lev D . Elevated level of pro-inflammatory eicosanoids and EPC dysfunction in diabetic patients with cardiac ischemia. Prostaglandins Other Lipid Mediat. 2013; 100-101:15-21. PMC: 4292900. DOI: 10.1016/j.prostaglandins.2012.12.002. View

4.
Lakhkar A, Dhagia V, Joshi S, Gotlinger K, Patel D, Sun D . 20-HETE-induced mitochondrial superoxide production and inflammatory phenotype in vascular smooth muscle is prevented by glucose-6-phosphate dehydrogenase inhibition. Am J Physiol Heart Circ Physiol. 2016; 310(9):H1107-17. PMC: 4867393. DOI: 10.1152/ajpheart.00961.2015. View

5.
Hoopes S, Garcia V, Edin M, Schwartzman M, Zeldin D . Vascular actions of 20-HETE. Prostaglandins Other Lipid Mediat. 2015; 120:9-16. PMC: 4575602. DOI: 10.1016/j.prostaglandins.2015.03.002. View